Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicDental EquipmentDental ImplantJoint Implant

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758037

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758037

Biological Implants

PUBLISHED:
PAGES: 281 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Biological Implants Market to Reach US$11.0 Billion by 2030

The global market for Biological Implants estimated at US$8.6 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Biological Autografts, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.3 Billion by the end of the analysis period. Growth in the Biological Allografts segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Biological Implants market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Biological Implants Market - Key Trends & Drivers Summarized

Why Are Biological Implants Reshaping the Future of Regenerative Medicine and Surgical Interventions?

Biological implants are revolutionizing modern medicine by providing biologically compatible solutions that facilitate natural healing, tissue integration, and functional restoration in a variety of clinical applications. Unlike synthetic implants made from metals or plastics, biological implants are derived from natural tissues-either human (autografts or allografts) or animal (xenografts)-that are processed to ensure biocompatibility and sterility while retaining essential biological structures. These implants are increasingly used in orthopedic, cardiovascular, dental, ophthalmic, and reconstructive surgeries due to their ability to promote cellular growth, reduce immune rejection, and improve healing outcomes. Their widespread adoption is also being driven by the global increase in age-related degenerative diseases, trauma-related injuries, and surgical interventions such as joint replacements and organ reconstructions. For example, in orthopedic procedures, biological scaffolds and grafts are replacing or augmenting damaged ligaments, tendons, and cartilage with more natural recovery paths and fewer complications. Similarly, in cardiovascular surgery, biological heart valves are favored over mechanical alternatives for their lower thrombogenic risk and reduced need for lifelong anticoagulation therapy. The demand for biologically derived implants is further amplified by patient preference for minimally invasive procedures, faster recovery times, and lower incidences of long-term foreign body reactions. As healthcare shifts towards regenerative and personalized medicine, biological implants stand at the forefront of surgical innovation-transforming the way clinicians approach healing and structural repair.

How Are Technological Innovations Enhancing the Performance and Reliability of Biological Implants?

The performance and reliability of biological implants have been significantly improved by ongoing advancements in tissue engineering, material science, and biomedical technologies. Decellularization techniques have become more precise, allowing the removal of donor cellular content while preserving the extracellular matrix that supports host tissue integration. This innovation greatly reduces immunogenicity while maintaining the mechanical integrity necessary for load-bearing or structural applications. Furthermore, sterilization methods using gamma irradiation, supercritical CO2, and ethylene oxide are now refined to ensure safety without degrading tissue properties. Biofabrication technologies, including 3D bioprinting, have enabled the creation of customized implantable scaffolds embedded with cells and growth factors tailored to the patient’s anatomy and healing requirements. Nanotechnology is also contributing to this progress, with nanostructured coatings and drug delivery systems being integrated into biological implants to release antibiotics, anti-inflammatory agents, or regenerative compounds over time. Additionally, researchers are developing composite biological implants that combine natural tissues with bioresorbable polymers to enhance structural strength and tailor degradation rates. Improvements in imaging technologies like MRI and CT have facilitated preoperative planning and better matching of implants with host tissue, improving surgical outcomes and reducing postoperative complications. Digital health tools and wearables are starting to be paired with implants to monitor integration and healing in real time, marking the beginning of smart implant systems. Together, these technological advancements are not only improving the quality and safety of biological implants but are also broadening their applicability across complex medical challenges.

Which Medical Fields and Global Regions Are Leading the Surge in Biological Implant Adoption?

The adoption of biological implants is surging across multiple medical fields where tissue restoration and biocompatibility are paramount. Orthopedics remains a dominant sector, where implants like meniscal allografts, bone grafts, and tendon scaffolds are used to repair sports injuries, fractures, and degenerative conditions. Cardiovascular medicine is another major driver, particularly in the use of bioprosthetic heart valves, vascular patches, and pericardial tissues for valve repair and congenital defect correction. Reconstructive and plastic surgery heavily relies on dermal matrices and collagen scaffolds to support tissue regeneration following trauma, burns, or cosmetic enhancements. In dental surgery, biological membranes and bone substitutes are used for periodontal repairs and implant anchoring. Ophthalmology and neurosurgery are also integrating biologically based materials to repair dura mater or ocular tissues with minimal rejection risk. Regionally, North America leads the global market due to high healthcare expenditure, advanced surgical infrastructure, and favorable reimbursement systems. The United States, in particular, benefits from a robust transplant network and strong regulatory frameworks that ensure safety and innovation. Europe follows closely, driven by government support for regenerative medicine and the presence of leading biotech firms. Asia-Pacific is the fastest-growing market, fueled by rising healthcare investments, increasing awareness, and a large patient base in countries like China, India, and Japan. Latin America and the Middle East are emerging regions where improvements in healthcare access and the rise of medical tourism are boosting demand. Across these varied geographies, the increasing focus on patient-centric, tissue-compatible solutions is making biological implants a preferred choice over traditional synthetic options.

What Is Fueling the Growth in the Global Biological Implants Market?

The growth in the global biological implants market is driven by a multifaceted combination of medical, technological, demographic, and policy-related factors that are collectively reshaping surgical care. Foremost among these is the rising global burden of chronic diseases, such as osteoarthritis, cardiovascular disorders, and diabetes, which frequently necessitate implant-based surgical interventions. The growing aging population, particularly in developed and middle-income countries, also contributes to increased demand, as elderly patients are more likely to undergo joint replacements, valve surgeries, and tissue reconstruction procedures. Moreover, the trend toward minimally invasive and regenerative treatments is pushing clinicians to choose biologically compatible implants that promote natural healing while reducing surgical trauma and recovery times. Technological innovation, including advancements in bioengineering, 3D bioprinting, and cellular therapies, is expanding the range and effectiveness of implantable biological materials. Regulatory bodies such as the FDA and EMA are streamlining approval pathways for biologics, recognizing their potential to address unmet clinical needs. Insurance coverage and reimbursement models are also evolving to accommodate these newer solutions, particularly as clinical evidence continues to validate their long-term safety and efficacy. Furthermore, increasing collaboration between academic institutions, biotech startups, and established medtech companies is accelerating research, commercialization, and global distribution. Environmental and ethical concerns around synthetic implants are also prompting a shift toward biodegradable and biologically derived alternatives. Collectively, these drivers are positioning biological implants as a critical component of next-generation medical care, where restoration of function is achieved not through replacement alone, but through true biological integration and regeneration.

SCOPE OF STUDY:

The report analyzes the Biological Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Biological Autografts, Biological Allografts, Biological Xenografts); Application (Cardiovascular Implants Application, Orthopedic Implants Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Aroa Biosurgery
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical Inc.
  • Dentsply Sirona Inc.
  • Edwards Lifesciences Corporation
  • Globus Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson (DePuy Synthes)
  • LivaNova PLC
  • Mathys Ltd Bettlach
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive Inc.
  • Smith & Nephew plc
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36381

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Organ Failures Throws the Spotlight on Biological Implants
    • Advancements in Regenerative Medicine Spur Growth in Bioengineered and Cell-Based Implant Technologies
    • Here's How Aging Populations Are Expanding the Addressable Market for Cardiovascular and Orthopedic Implants
    • Increased Adoption of Xenografts and Allografts Strengthens the Business Case for Biologic Materials
    • Minimally Invasive Surgical Trends Drive Demand for Bio-Compatible and Resorbable Implant Solutions
    • Tissue Engineering Innovations Enhance Functional Integration and Longevity of Biological Implants
    • Global Growth in Organ Transplants and Reconstructive Surgeries Fuels Use of Soft Tissue Biological Scaffolds
    • Here's the Story: How 3D Bioprinting Is Creating Future Opportunities in Patient-Specific Biological Implants
    • Integration with Smart and Drug-Eluting Technologies Propels Next-Generation Implant Development
    • Rising Focus on Post-Surgical Healing and Biocompatibility Fuels Demand for Naturally Derived Implant Materials
    • Expansion of Biologic Mesh Use in Hernia and Pelvic Floor Repairs Drives Institutional Procurement
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biological Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Biological Autografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Biological Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biological Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Cardiovascular Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Orthopedic Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!